azathioprine and deferoxamine

azathioprine has been researched along with deferoxamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Schimmelpfennig, W; Schneider, G; Wagner, K; Zimmermann, HB1
Cerruti Mainardi, P; Massimo, L1
Carcassi, U1
Andreani, M; Gaziev, J; Lucarelli, G; Polchi, P; Sodani, P1

Reviews

1 review(s) available for azathioprine and deferoxamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for azathioprine and deferoxamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
[Indications for treatment of chronic hepatitis and liver cirrhosis and their complications. 1. Treatment of chronic hepatitis and liver cirrhosis].
    Zeitschrift fur arztliche Fortbildung, 1974, Jun-01, Volume: 68, Issue:11

    Topics: Azathioprine; Cholecalciferol; Chronic Disease; Deferoxamine; Glucocorticoids; Hepatitis; Humans; Liver Cirrhosis; Physical Therapy Modalities; Vitamin A; Vitamin K

1974
[Nosological classification and new therapeutic trends in idiopathic pulmonary hemosiderosis].
    Minerva pediatrica, 1966, Dec-15, Volume: 18, Issue:39

    Topics: Adrenal Cortex Hormones; Azathioprine; Blood Protein Electrophoresis; Child, Preschool; Deferoxamine; Edetic Acid; Female; Hemosiderosis; Humans; Immunoelectrophoresis; Lung Diseases; Splenectomy

1966
[Modern therapeutic possibilities in Cooley's disease].
    Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica, 1966, Volume: 15, Issue:2

    Topics: Adolescent; Antibody Formation; Azathioprine; Betamethasone; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Drug Tolerance; Humans; Immune Tolerance; Infant; Methotrexate; Thalassemia

1966
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Annals of the New York Academy of Sciences, 2005, Volume: 1054

    Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical Protocols; Combined Modality Therapy; Comorbidity; Deferoxamine; Disease-Free Survival; Erythrocyte Transfusion; Erythropoietin; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hemosiderosis; Humans; Hydroxyurea; Immunosuppressive Agents; Iron Chelating Agents; Life Tables; Liver Cirrhosis; Male; Phlebotomy; Postoperative Complications; Survival Analysis; Thalassemia; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2005